| E3 ligase ligands in successful PROTACs: an overview of syntheses and linker attachment points A Bricelj, C Steinebach, R Kuchta, M Gütschow, I Sosič Frontiers in chemistry 9, 707317, 2021 | 128 | 2021 |
| Systematic exploration of different E3 ubiquitin ligases: an approach towards potent and selective CDK6 degraders C Steinebach, YLD Ng, I Sosič, CS Lee, S Chen, S Lindner, LP Vu, ... Chemical science 11 (13), 3474-3486, 2020 | 101 | 2020 |
| E3 ligase ligand chemistries: from building blocks to protein degraders I Sosič, A Bricelj, C Steinebach Chemical Society Reviews 51 (9), 3487-3534, 2022 | 66 | 2022 |
| A MedChem toolbox for cereblon-directed PROTACs C Steinebach, I Sosič, S Lindner, A Bricelj, F Kohl, YLD Ng, M Monschke, ... MedChemComm 10 (6), 1037-1041, 2019 | 56 | 2019 |
| Influence of linker attachment points on the stability and neosubstrate degradation of cereblon ligands A Bricelj, YL Dora Ng, D Ferber, R Kuchta, S Müller, M Monschke, ... ACS Medicinal Chemistry Letters 12 (11), 1733-1738, 2021 | 36 | 2021 |
| A facile synthesis of ligands for the von Hippel–Lindau E3 ligase C Steinebach, SA Voell, LP Vu, A Bricelj, I Sosič, G Schnakenburg, ... Synthesis 52 (17), 2521-2527, 2020 | 24 | 2020 |
| Medication review service implementation in community pharmacy settings: scoping review with focus on implementation studies J Brandt, ML Lê, S Jantscher, A Bricelj, C Louizos, S Ng, K Sibley Research in Social and Administrative Pharmacy 16 (7), 875-885, 2020 | 16 | 2020 |
| Leveraging ligand affinity and properties: discovery of novel benzamide-type cereblon binders for the design of PROTACs C Steinebach, A Bricelj, A Murgai, I Sosic, L Bischof, YLD Ng, C Heim, ... Journal of medicinal chemistry 66 (21), 14513-14543, 2023 | 6 | 2023 |
| Expanding the Structural Diversity at the Phenylene Core of Ligands for the von Hippel–Lindau E3 Ubiquitin Ligase: Development of Highly Potent Hypoxia-Inducible Factor-1α … LP Vu, CJ Diehl, R Casement, AG Bond, C Steinebach, N Strasek, ... Journal of Medicinal Chemistry 66 (18), 12776-12811, 2023 | 2 | 2023 |
| Expanding the Structural Diversity at the Phenylene Core of Ligands for the von Hippel-Lindau (VHL) E3 Ubiquitin Ligase: Development of Highly Potent Hypoxia-Inducible Factor … LP Vu, C Diehl, R Casement, A Bond, C Steinebach, N Strasek, A Bricelj, ... | 1 | 2023 |
| Heterobifunctional ligase recruiters enable pan-degradation of inhibitor of apoptosis proteins YLD Ng, A Bricelj, JA Jansen, A Murgai, K Peter, KA Donovan, ... Journal of medicinal chemistry 66 (7), 4703-4733, 2023 | 1 | 2023 |
| Design, synthesis, and evaluation of BCL‐2 targeting PROTACs A Bricelj, YLD Ng, M Gobec, R Kuchta, W Hu, Š Javornik, M Rožič, ... Chemistry–A European Journal, e202400430, 2024 | | 2024 |
| Načrtovanje, sinteza in vrednotenje himernih molekul za inducirano razgradnjo proteinov, vpletenih v patogenezo malignih obolenj A Bricelj Univerza v Ljubljani, Fakulteta za farmacijo, 2023 | | 2023 |
| PROTACS as tools for the modulation of pharmacological targets I Sosic, C Steinebach, A Bricelj, YLD Ng, M Gobec, J Kroenke, RJ Pieters, ... FEBS OPEN BIO 11, 100-100, 2021 | | 2021 |
| PROTAC-MEDIATED INACTIVATION OF E3 LIGASES: FROM TOOLS TO CANCER TREATMENT C Steinebach, YLD Ng, A Bricelj, I Sosič, J Krönke, M Gütschow Book of, 290, 0 | | |
Izidor SosičResearch Scientist, Faculty of Pharmacy, University of Ljubljana在 ffa.uni-lj.si 的电子邮件经过验证
